Accuracy of FDG-PET/CT in Detecting Residual Disease after CRT

Researchers in Helsinki, Finland, examined the effectiveness of FDG-PET/CT in detecting residual disease after definitive chemotherapy and radiotherapy for HNSCC.

How Does Your Work Life Balance Compare to Your Peers?

We recently asked our readers some questions about their work/life balance as it relates to their oncology-related careers.

Metronomic Chemotherapy, Recent Research Overview

Early studies show that continual low-dose chemotherapy lessens toxicity.

Remembering Dr. Abraham Borbor

Dr. Burtness of the CTA Advisory Board reflects on the loss of the only certified internist in Liberia who recently died of Ebola.

Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Patients treated with enzalutamide had prolonged time to first skeletal-related event, pain progression, and health-related QoL deterioration compared with placebo.

Pasireotide for Patients With Pancreatic Cancer

After positive results, there is debate regarding the roll out of pasireotide for patients with pancreatic cancer undergoing surgery.

HPV Test for Cervical Cancer Screening

A review of data suggests that HPV testing alone every 3 years provides a high level of reassurance against cervical cancer.

ZYDELIG® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia

This slideshow reviews drug information for ZYDELIG® (idelalisib), indicated for relapsed chronic lymphoma.

Featured Videos

Viewpoints & Feature Articles

Metronomic Chemotherapy: A Steady Tempo for Maintenance Therapy

Metronomic Chemotherapy: A Steady Tempo for Maintenance Therapy

Early studies show that continual low-dose chemotherapy lessens toxicity.

New Agent May Help Lower Morbidity and Improve Outcomes in Patients With Pancreatic Cancer

New Agent May Help Lower Morbidity and Improve Outcomes in Patients With Pancreatic Cancer

After positive results, there is debate regarding the roll out of pasireotide for patients with pancreatic cancer undergoing surgery.

Human Papillomavirus (HPV) Test May Be More Accurate Than Pap Test for Cervical Cancer Screening

Human Papillomavirus (HPV) Test May Be More Accurate Than Pap Test for Cervical Cancer Screening

A review of data suggests that HPV testing alone every 3 years provides a high level of reassurance against cervical cancer.

FDG-PET/CT in the Assessment of Treatment Response after Oncologic Treatment of Head and Neck Squamous Cell Carcinoma

FDG-PET/CT in the Assessment of Treatment Response after Oncologic Treatment of Head and Neck Squamous Cell Carcinoma

18F-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) is used to monitor treatment response after definitive (chemo)radiotherapy for head and neck squamous cell carcinoma, but its usefulness remains controversial.

New Therapies in T-cell Lymphoma

New Therapies in T-cell Lymphoma

Biomarker-driven chemotherapeutics is becoming a critical part of the state-of-the-art treatment in early- and late-phase clinical trials involving patients with T-cell lymphoma.

Diarrhea and Patients With Cancer

Diarrhea and Patients With Cancer

Diarrhea is a treatment symptom as common as hair loss but with deadlier implications.


Editorial Advisory Board

 

Barbara Ann Burtness, MD

Steven Cohen, MD

E. David Crawford, MD

Don S. Dizon, MD, FACP

Jeffrey M. Farma, MD

Edith A. Perez, MD

Neal D. Shore, MD, FACS

Mark A. Socinski, MD

Mario Sznol, MD

Click here for complete profiles


From Oncology Nurse Advisor

Sign Up for Free e-newsletters

CTA Community Poll

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs